Scientific Information on Symptoms of Alzheimer’s
Symptoms of Alzheimer’s
Summary of Symptoms of Alzheimer’s
Scientific Information on Symptoms of Alzheimer’s
Easily stay on top of nutrition research
Become an Examine.com member to get access to the latest research. 150+ studies summarized across 25 different categories every month.
Becoming a member also unlocks our study database of 400+ supplements and their effects on 600+ health outcomes.
Already a member? Click here to log in.
Make informed decisions about your health
Human Effect Matrix
Unlocked for Examine members
The Human Effect Matrix looks at human studies to tell you what supplements affect Symptoms of Alzheimer’s.
Full details on all Symptoms of Alzheimer’s supplements are available to Examine members.
| Grade | Level of Evidence [show legend] |
|---|---|
|
Robust research conducted with repeated double-blind clinical trials |
|
Multiple studies where at least two are double-blind and placebo controlled |
|
Single double-blind study or multiple cohort studies |
|
Uncontrolled or observational studies only |
|
Level of Evidence
?
The amount of high quality evidence. The more
evidence, the more we can trust the results.
|
Supplement |
Magnitude of effect
?
The direction and size of the supplement's impact on
each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
|
Consistency of research results
?
Scientific research does not always agree. HIGH or
VERY HIGH means that most of the scientific research agrees.
|
Notes |
|---|---|---|---|---|
|
|
Minor
|
Very High See all 5 studies |
Cognitive impairment that is associated with Alzheimer's appears to be significantly reduced with ginkgo supplementation.
|
|
|
|
Notable
|
- See study |
At least among nutraceuticals, Alpha-GPC appears to significantly improve cognition in persons with Alzheimer's disease at the dose of 1,200mg when taken as a daily supplement over a prolonged period of time.
|
|
|
|
Notable
|
Very High See 2 studies |
Very high dose Vitamin E supplementation in the form of α-tocopherol (2,000 IU) appears to reduce the rate of cognitive decline in persons with moderate to severe Alzheimer's Disease with a potency comparable to selegiline. Currently no research on lower (more standard) doses, and there appears to be no influence on minor AD or cognitive decline not characterized by AD.
|
|
|
|
||||
|
|
||||
|
|
||||
|
|
||||
Stay on top of the latest research
Become an Examine Personalized member to access the latest nutrition research on over 400 supplements across more than 600 different health goals, outcomes, conditions, and more. Information tailored to you, updated every month.
Bonus: unlock the supplement Human Effect Matrix and all health topics on Examine.com.
